Talking Euretina

Episode 50: David Yorston on the Euretina/BEAVRS Database

Ahead of his prestigious Gisbert Richard lecture at this year's upcoming Euretina congress in Barcelona, David Yorston speaks to Euretina board member and former president Mr Alistair Laidlaw about his impressive career highlights and what we have learned so far from the BEAVRS Database

Episode 49: The challenges and opportunities for young retina specialists

In this episode, Drs Kristina Pfau (Switzerland) and Elon Van Dijk (Netherlands) will talk about the importance of the YOURS committee, representing young retina specialists across Europe. They'll also discuss the opportunities that lie ahead and the challenges that are faced by early career clinicians and researchers

Episode 48: Assessing Visual Deficits in Intermediate AMD

In this podcast, Prof Frank Holz (Germany) discusses assessment of visual dysfunction in Intermediate AMD in the context of the Macustar trial with Dr Hannah Dunbar, Principal Optometrist at Moorfields and UCL

Episode 47: Gut bacteria and eye disease?

In this podcast, Bart Leroy and Mark Pennesi discuss a provocative paper in Cell that seems to draw a link between bacteria normally found in our gut and retinal diseases such as Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP). This episode was an initiative of EURETINA in collaboration with ERN-EYE (European Reference Network for Rare Eye Disease). 

Episode 46: How do you investigate your uveitis patient in 2024?

In this episode, Zohar Habot-Wilner (Israel) and Elisabetta Miserocchi (Italy) explore the key elements of clinical examination and how to approach work up when treating patients presenting with Uveitis. The discussion is chaired by Bahram Bodhagi (France)

Episode 45: Robert J Johnston on Lab-Grown Retinas

In this episode, something a little different from the world of basic science: an interview with Bob J Johnston of Johns Hopkins who has been working with retinal organoids for the past decade. How are they made? What does industry think of them and will they one day become the default paradigm for retinal clinical research? Chaired by Jonathan McCrea

Episode 44: Second Eye Risk: Navigating Prophylaxis in Retinal Detachment, GRT, and Sticklers

In this episode, we hear from an expert panel as they delve into the critical topic of second eye risk of retinal detachment (RD) and discuss approaches to prophylaxis. With Alistair Laidlaw (UK), Patricia Udaondo (Spain) and David Steel (UK)

Episode 43: Spoilt for choice - the many treatments now available for AMD and DME

Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes

Episode 42: A Guide to Radiation Maculopathy

In this podcast episode, we will dig into the subject of radiation maculopathy, the most common complication following the irradiation of intraocular tumours, with a panel of ocular oncologists from across Europe: Hibba Quhill (UK), Iwona Rospond-Kubiak (Poland), Emine Kilic (Netherlands) and Raffaele Parrozzani (Italy).

Episode 41: Ophthalmologica spotlight episode

In this episode we look at two very interesting papers published in the latest editions of Ophthalmologica - Martin Busch presents his work on using microRNA as biomarkers for retinal disease and the panel discuss Christina Weisheit's paper on Co2 emissions from the ophthalmic OR. Chaired by Patricia Udaondo, Matias Iglicki and Andreas Ebneter.

 

Links to papers: 

https://karger.com/oph/article/246/3-4/169/861433/High-Impact-Actions-to-Reduce-the-Carbon-Dioxide

https://karger.com/oph/article/246/3-4/227/861182/Circulating-MicroRNAs-as-Biomarker-for-Vessel?searchresult=1